Povidone iodine ointment and solutions are available in the market under various popular brands such as Betadine and Wokadine.
Company claims new use for kala jeera extract, provoking alarmed campaigners here and abroad; says reaction not based on facts.
If the company manages to get a go-ahead from the regulator for this plant, it might result in resumption of supplies of several of their products, barred from the US last year.
Roadblocks ahead as these medicines could face new clinical tests, more scrutiny
The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.
Various domestic companies such as Ranbaxy, Wockhardt and Agila Specialities recently came under the US FDA scanner for lapse in manufacturing practices.
.jpg)
The Drugs Controller General of India is considering the recommendations of its advisory body to revoke the suspension of the sale of analgin-based medicines in the country.
Move follows a spate of international regulatory enforcements on Indian drug firms.
According to villagers in the region, builders have been doing the rounds of the area, trying to spot suitable locations for residential projects.
Importers protest as food safety regulator demands adherence to recent law on labelling, blocks entry at ports for packs with stickers.
Govt wants firms to remove suffixes & prefixes to original names of these drugs.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
Say heavy penalties for medical errors might raise health care costs and make practitioners too cautious, says Sushmi Dey
As many as 150 applications are stuck at evaluation stage, says official.
Ranbaxy's US factory, Ohm Laboratories, is learnt to have got a clean chit from the American regulator. This US facility was under surveillance of the Food and Drug Administration (FDA) since the end of 2012.
Happy hours, a discount concept popular across bars, restaurants and multiplexes, is now catching up in the health care sector, too.
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
The move comes in the wake of many facilities of Ranbaxy in India being barred by the US Food and Drugs Administration for supplying medicines to the US.
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances